Enteric nervous system a-synuclein immunoreactivity in idiopathic REM sleep behavior disorder

Neurology

Volumn 85, Issue 20, 2015, Pages 1761-1768

  Sprenger, Fabienne S ^a   Stefanova, Nadia ^a   Gelpi, Ellen ^b   Seppi, Klaus ^a   Navarro Otano, Judith ^b   Offner, Felix ^c   Vilas, Dolores ^b   Valldeoriola, Francesc ^b   Pont Sunyer, Claustre ^b   Aldecoa, Iban ^b   Gaig, Carles ^b   Gines, Angels ^b   Cuatrecasas, Miriam ^b   Högl, Birgit ^a   Frauscher, Birgit ^a   Iranzo, Alex ^b   Wenning, Gregor K ^a   Vogel, Wolfgang ^a   Tolosa, Eduardo ^b   Poewe, Werner ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b HOSPITAL CLÍNIC   (Spain)

^c Federal Academic Teaching Hospital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

15G7 ANTIBODY; ALPHA SYNUCLEIN; ANTIBODY; BIOLOGICAL MARKER; UNCLASSIFIED DRUG;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLON BIOPSY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE INNERVATION; MALE; PARASOMNIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; TISSUE PREPARATION; CHEMISTRY; COLON; INNERVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; REM SLEEP BEHAVIOR DISORDER; SUBMUCOUS PLEXUS;

AGED; ALPHA-SYNUCLEIN; BIOMARKERS; COLON; ENTERIC NERVOUS SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REM SLEEP BEHAVIOR DISORDER; SUBMUCOUS PLEXUS;

EID: 84947428180     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002126     Document Type: Article

References (32)

1. Den HJW, Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 1960; 23: 283-290
2. Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alphasynuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's diseaserelated brain pathology. Neurosci Lett 2006; 396: 67-72
3. Beach TG, Adler CH, Sue LI, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010; 119: 689-702
4. Pouclet H, Lebouvier T, Coron E, et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol Dis 2012; 45: 305-309
5. Lebouvier T, Neunlist M, Bruley des Varannes S, et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One 2010; 5: e12728
6. Shannon KM, Keshavarzian A, Mutlu E, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord 2012; 27: 709-715
7. Gold A, Turkalp ZT, Munoz DG. Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease. Mov Disord 2013; 28: 237-240
8. Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord 2012; 27: 716-719
9. Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eyemovement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006; 5: 572-577
10. Iranzo A, Serradell M, Vilaseca I, et al. Longitudinal assessment of olfactory function in idiopathic REMsleep behavior disorder. Parkinsonism Relat Disord 2013; 19: 600-604
11. Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 2013; 14: 744-748
12. Postuma RB, Gagnon JF, Bertrand JA, Genier Marchand D, Montplaisir JY. Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 2015; 84: 1104-1113
13. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
14. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129-2170
15. Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulfe JM. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord 2014; 29: 991-998
16. Bottner M, Zorenkov D, Hellwig I, et al. Expression pattern and localization of alpha-synuclein in the human enteric nervous system. Neurobiol Dis 2012; 48: 474-480
17. Visanji NP, Marras C, Kern DS, et al. Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 2015; 84: 609-616
18. Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 2012; 124: 665-680
19. Fujiwara H, Hasegawa M, Dohmae N, et al. Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002; 4: 160-164
20. Tenreiro S, Eckermann K, Outeiro TF. Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci 2014; 7: 42
21. Angot E, Steiner JA, Hansen C, Li JY, Brundin P. Are synucleinopathies prion-like disorders? Lancet Neurol 2010; 9: 1128-1138
22. Pan-Montojo F, Schwarz M, Winkler C, et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep 2012; 2: 898
23. Orimo S, Uchihara T, Nakamura A, et al. Axonal alphasynuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008; 131: 642-650
24. Doppler K, Ebert S, Uceyler N, et al. Cutaneous neuropathy in Parkinson's disease: a window into brain pathology. Acta Neuropathol 2014; 128: 99-109
25. Pouclet H, Lebouvier T, Coron E, Des Varannes SB, Neunlist M, Derkinderen P. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease. Neurogastroenterol Motil 2012; 24: e202-e205. doi: 10.1111/j.1365-2982.2012.01887.x
26. Wang N, Gibbons CH, Lafo J, Freeman R. Alpha-synuclein in cutaneous autonomic nerves. Neurology 2013; 81: 1604-1610
27. Donadio V, Incensi A, Leta V, et al. Skin nerve alphasynuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology 2014; 82: 1362-1369
28. Gelpi E, Navarro-Otano J, Tolosa E, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord 2014; 29: 1010-1018
29. Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 2011; 69: 811-818
30. Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 2012; 135: 1860-1870
31. Iranzo A, Lomena F, Stockner H, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol 2010; 9: 1070-1077
32. Iranzo A, Stockner H, Serradell M, et al. Five-year followup of substantia nigra echogenicity in idiopathic REM sleep behavior disorder. Mov Disord 2014; 29: 1774-1780